Advisor Net Financial, Inc Nektar Therapeutics Call Options Transaction History

Advisor Net Financial, Inc

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Oct 15, 2021	SELL	$13.07 - $18.84 $457,450 - $659,400	-35,000 Closed	0 $0
Q2 2021 Jul 06, 2021	SELL	$16.52 - $20.4 $82,600 - $102,000	-5,000 Reduced 12.5%	35,000 $600,000
Q1 2021 Apr 14, 2021	SELL	$16.56 - $25.46 $413,999 - $636,500	-25,000 Reduced 38.46%	40,000 $800,000
Q4 2020 Feb 04, 2021	BUY	$15.77 - $19.03 $523,564 - $631,796	33,200 Added 104.4%	65,000 $1.11 Million
Q3 2020 Nov 06, 2020	BUY	$16.59 - $24.79 $29,862 - $44,622	1,800 Added 6.0%	31,800 $528,000
Q1 2020 May 14, 2020	BUY	$14.47 - $27.96 $383,455 - $740,940	26,500 Added 757.14%	30,000 $536,000
Q4 2019 Feb 12, 2020	BUY	$15.87 - $23.12 $31,740 - $46,240	2,000 Added 133.33%	3,500 $77,000
Q3 2019 Oct 23, 2019	BUY	$16.91 - $36.27 $8,455 - $18,135	500 Added 50.0%	1,500 $27,000
Q2 2019 Jul 15, 2019	BUY	$31.0 - $36.3 $31,000 - $36,300	1,000 New	1,000 $36,000

152

130M

92.7K

4.9K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $139M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.